Page 210 - Read Online

Zhu et al. Endoglin and cerebral vascular diseases

neuroprotection. J Cell Mol Med 2005;9:85-102. DJ, Kutryk MJ. Circulating angiogenic cell dysfunction in patients with
75. Liu HM. Neovasculature and blood-brain barrier in ischemic brain hereditary hemorrhagic telangiectasia. PLoS One 2014;9:e89927.
infarct. Acta Neuropathol 1988;75:422-6. 93. Sabri M, Ai J, Macdonald RL. Nitric oxide related pathophysiological
76. Slevin M, Kumar P, Gaffney J, Kumar S, Krupinski J. Can angiogenesis changes following subarachnoid haemorrhage. Acta Neurochir Suppl
be exploited to improve stroke outcome? Mechanisms and therapeutic 2011;110:105-9.
potential. Clin Sci (Lond) 2006;111:171-83. 94. Testai FD, Aiyagari V, Hillmann M, Amin-Hanjani S, Dawson G,
77. Miller DW, Graulich W, Karges B, Stahl S, Ernst M, Ramaswamy Gorelick P. Proof of concept: endogenous antiangiogenic factors
A, Sedlacek HH, Muller R, Adamkiewicz J. Elevated expression of predict the occurrence of symptomatic vasospasm post subarachnoid
endoglin, a component of the TGF-beta-receptor complex, correlates with hemorrhage. Neurocrit Care 2011;15:416-20.
proliferation of tumor endothelial cells. Int J Cancer 1999;81:568-72. 95. Dietmann A, Lackner P, Fischer M, Broessner G, Pfausler B, Helbok
78. Torsney E, Charlton R, Parums D, Collis M, Arthur HM. Inducible R, Schmutzhard E, Beer R. Soluble endoglin and transforming growth
expression of human endoglin during inflammation and wound healing factor-beta(1) and the development of vasospasm after spontaneous
in vivo. Inflamm Res 2002;51:464-70. subarachnoid hemorrhage: a pilot study. Cerebrovasc Dis 2012;33:16-22.
79. Slevin M, Krupinski J, Rovira N, Turu M, Luque A, Baldellou M, 96. Lackner P, Dietmann A, Beer R, Fischer M, Broessner G, Helbok
Sanfeliu C, de Vera N, Badimon L. Identification of pro-angiogenic R, Marxgut J, Pfausler B, Schmutzhard E. Cellular microparticles
markers in blood vessels from stroked-affected brain tissue using laser- as a marker for cerebral vasospasm in spontaneous subarachnoid
capture microdissection. BMC Genomics 2009;10:113. hemorrhage. Stroke 2010;41:2353-7.
80. van Laake LW, van den Driesche S, Post S, Feijen A, Jansen MA, 97. Li CG, Bethell H, Wilson PB, Bhatnagar D, Walker MG, Kumar S. The
Driessens MH, Mager JJ, Snijder RJ, Westermann CJ, Doevendans significance of CD105, TGFbeta and CD105/TGFbeta complexes in
PA, van Echteld CJ, ten Dijke P, Arthur HM, Goumans MJ, Lebrin coronary artery disease. Atherosclerosis 2000;152:249-56.
F, Mummery CL. Endoglin has a crucial role in blood cell-mediated 98. Luque A, Turu M, Juan-Babot O, Cardona P, Font A, Carvajal A, Slevin
vascular repair. Circulation 2006;114:2288-97. M, Iborra E, Rubio F, Badimon L, Krupinski J. Overexpression of
81. Jerkic M, Rodriguez-Barbero A, Prieto M, Toporsian M, Pericacho hypoxia/inflammatory markers in atherosclerotic carotid plaques. Front
M, Rivas-Elena JV, Obreo J, Wang A, Perez-Barriocanal F, Arevalo Biosci 2008;13:6483-90.
M, Bernabeu C, Letarte M, Lopez-Novoa JM. Reduced angiogenic 99. Bot PT, Hoefer IE, Sluijter JP, van Vliet P, Smits AM, Lebrin F, Moll
responses in adult Endoglin heterozygous mice. Cardiovasc Res F, de Vries JP, Doevendans P, Piek JJ, Pasterkamp G, Goumans MJ.
2006;69:845-54. Increased expression of the transforming growth factor-beta signaling
82. Xu B, Wu YQ, Huey M, Arthur HM, Marchuk DA, Hashimoto T, Young pathway, endoglin, and early growth response-1 in stable plaques.
WL, Yang GY. Vascular endothelial growth factor induces abnormal Stroke 2009;40:439-47.
microvasculature in the endoglin heterozygous mouse brain. J Cereb 100. Luque A, Slevin M, Turu MM, Juan-Babot O, Badimon L, Krupinski J.
Blood Flow Metab 2004;24:237-44. CD105 positive neovessels are prevalent in early stage carotid lesions,
83. Rossi E, Sanz-Rodriguez F, Eleno N, Duwell A, Blanco FJ, Langa C, and correlate with the grade in more advanced carotid and coronary
Botella LM, Cabanas C, Lopez-Novoa JM, Bernabeu C. Endothelial plaques. J Angiogenes Res 2009;1:6.
endoglin is involved in inflammation: role in leukocyte adhesion and 101. Rathouska J, Vecerova L, Strasky Z, Slanarova M, Brcakova E,
transmigration. Blood 2013;121:403-15. Mullerova Z, Andrys C, Micuda S, Nachtigal P. Endoglin as a possible
84. Lakhan SE, Kirchgessner A, Hofer M. Inflammatory mechanisms in marker of atorvastatin treatment benefit in atherosclerosis. Pharmacol
ischemic stroke: therapeutic approaches. J Transl Med 2009;7:97. Res 2011;64:53-9.
85. Hayakawa K, Qiu J, Lo EH. Biphasic actions of HMGB1 signaling in 102. Research Committee on the Pathology and Treatment of Spontaneous
inflammation and recovery after stroke. Ann N Y Acad Sci 2010;1207:50-7. Occlusion of the Circle of Willis; Health Labour Sciences Research
86. Toporsian M, Gros R, Kabir MG, Vera S, Govindaraju K, Eidelman Grant for Research on Measures for Infractable Diseases. Guidelines for
DH, Husain M, Letarte M. A role for endoglin in coupling eNOS diagnosis and treatment of moyamoya disease (spontaneous occlusion
activity and regulating vascular tone revealed in hereditary hemorrhagic of the circle of Willis). Neurol Med Chir (Tokyo) 2012;52:245-66.
telangiectasia. Circ Res 2005;96:684-92. 103. Takagi Y, Kikuta K, Nozaki K, Fujimoto M, Hayashi J, Imamura
87. Palmer RM, Ashton DS, Moncada S. Vascular endothelial cells H, Hashimoto N. Expression of hypoxia-inducing factor-1 alpha
synthesize nitric oxide from L-arginine. Nature 1988;333:664-6. and endoglin in intimal hyperplasia of the middle cerebral artery of
88. Perez-Gomez E, Jerkic M, Prieto M, del Castillo G, Martin-Villar E, patients with Moyamoya disease. Neurosurgery 2007;60:338-45;
Letarte M, Bernabeu C, Perez-Barriocanal F, Quintanilla M, Lopez- discussion 345.
Novoa JM. Impaired wound repair in adult endoglin heterozygous 104. Duffy AG, Ma C, Ulahannan SV, Rahma OE, Makarova-Rusher O,
mice associated with lower NO bioavailability. J Invest Dermatol Cao L, Yu Y, Kleiner DE, Trepel J, Lee MJ, Tomita Y, Steinberg
2014;134:247-55. SM, Heller T, Turkbey B, Choyke PL, Peer CJ, Figg WD, Wood
89. Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, BJ, Greten TF. Phase I and preliminary phase II study of TRC105 in
Bdolah Y, Lim KH, Yuan HT, Libermann TA, Stillman IE, Roberts D, combination with sorafenib in hepatocellular carcinoma. Clin Cancer
D’Amore PA, Epstein FH, Sellke FW, Romero R, Sukhatme VP, Letarte Res 2017;23:4633-41.
M, Karumanchi SA. Soluble endoglin contributes to the pathogenesis of 105. Hannan NJ, Brownfoot FC, Cannon P, Deo M, Beard S, Nguyen TV,
preeclampsia. Nat Med 2006;12:642-9. Palmer KR, Tong S, Kaitu’u-Lino TJ. Resveratrol inhibits release
90. Chen Y, Hao Q, Kim H, Su H, Letarte M, Karumanchi SA, Lawton of soluble fms-like tyrosine kinase (sFlt-1) and soluble endoglin
MT, Barbaro NM, Yang GY, Young WL. Soluble endoglin modulates and improves vascular dysfunction - implications as a preeclampsia
aberrant cerebral vascular remodeling. Ann Neurol 2009;66:19-27. treatment. Sci Rep 2017;7:1819.
91. Jerkic M, Rivas-Elena JV, Prieto M, Carron R, Sanz-Rodriguez F, 106. Brownfoot FC, Tong S, Hannan NJ, Hastie R, Cannon P, Kaitu’u-Lino
Perez-Barriocanal F, Rodriguez-Barbero A, Bernabeu C, Lopez-Novoa TJ. Effects of simvastatin, rosuvastatin and pravastatin on soluble fms-
JM. Endoglin regulates nitric oxide-dependent vasodilatation. FASEB J like tyrosine kinase 1 (sFlt-1) and soluble endoglin (sENG) secretion
2004;18:609-11. from human umbilical vein endothelial cells, primary trophoblast cells
92. Zucco L, Zhang Q, Kuliszewski MA, Kandic I, Faughnan ME, Stewart and placenta. BMC Pregnancy Childbirth 2016;16:117.

210 Neuroimmunology and Neuroinflammation ¦ Volume 4 ¦ October 17, 2017